Patents by Inventor Charles G. ARNOLD

Charles G. ARNOLD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dermal Delivery Compositions And Methods
    Publication number: 20180325916
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Application
    Filed: July 25, 2018
    Publication date: November 15, 2018
    Applicant: Agile Therapeutics, Inc.
    Inventors: Charles G. ARNOLD, Agis Kydonieus, Thomas M. Rossi, Alfred F. Altomari
  • TRANSDERMAL HORMONE DELIVERY
    Publication number: 20180078493
    Abstract: Compositions and devices for transdermal hormone delivery are disclosed. The compositions and devices include desogestrel and enable delivery of effective amounts of progestin without the use of skin permeation enhancers.
    Type: Application
    Filed: August 3, 2017
    Publication date: March 22, 2018
    Applicant: Agile Therapeutics, Inc.
    Inventors: Agis Kydonieus, Thomas M. Rossi, Charles G. Arnold, Ajay K. Banga, Vishal Sachdeva
  • DERMAL DELIVERY COMPOSITIONS AND METHODS
    Publication number: 20160250226
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Application
    Filed: May 11, 2016
    Publication date: September 1, 2016
    Applicant: Agile Therapeutics, Inc.
    Inventors: Charles G. ARNOLD, Agis KYDONIEUS, Thomas M. ROSSI, Alfred F. ALTOMARI
  • Dermal delivery compositions and methods
    Patent number: 9364487
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: June 14, 2016
    Assignee: Agile Therapeutics, Inc.
    Inventors: Charles G. Arnold, Agis Kydonieus, Thomas M. Rossi, Alfred F. Altomari
  • Transdermal Hormone Delivery
    Publication number: 20130195956
    Abstract: Compositions and devices for transdermal hormone delivery are disclosed. The compositions and devices include desogestrel and enable delivery of effective amounts of progestin without the use of skin permeation enhancers.
    Type: Application
    Filed: January 25, 2013
    Publication date: August 1, 2013
    Applicant: Agile Therapeutics, Inc.
    Inventors: Agis KYDONIEUS, Thomas M. ROSSI, Charles G. ARNOLD, Ajay K. BANGA, Vishal SACHDEVA
  • Dermal Delivery Compositions and Methods
    Publication number: 20130116222
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 9, 2013
    Inventors: Charles G. ARNOLD, Agis KYDONIEUS, Thomas M. ROSSI, Alfred F. ALTOMARI